ウィメンズヘルスの世界市場レポート 2025年

ウィメンズヘルスの市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.3％で580億7,000万米ドルに成長します。予測期間の成長は、婦人科における精密医療、女性に焦点を当てた臨床試験の増加、非侵襲的出生前検査の利用拡大、不妊治療へのアクセス拡大、メンタルヘルスへの注目の高まりに起因すると考えられます。予測期間における主な動向には、デジタルヘルスソリューション、不妊追跡とリプロダクティブヘルス、非ホルモン避妊オプション、妊産婦の健康と妊娠モニタリング、ウィメンズヘルス診断の革新、人工知能（AI）の統合などがあります。

ウィメンズヘルス市場の成長軌道を後押しする重要な促進要因として、女性中心の疾病の蔓延が高まっています。貧血、骨粗しょう症、乳がん、更年期障害など、家族歴、高齢化、月経の早期開始や55歳以降の閉経、肥満などの多様なリスク要因に起因する疾患の急増が、ウィメンズヘルス製品やサービスへの需要を煽っています。これらの製品は、女性の全体的な健康とウェルネスを優先しながら、これらの疾患の治療に対応しています。例えば、2023年1月に発表された米国がん協会の報告書では、子宮頸がんが米国女性のがん関連死亡の主要原因であるという歴史的状況が強調されています。2023年に米国で新たに診断される浸潤性子宮頸がんの推定症例数は13,960例で、死亡者数は約4,310人と予測されています。したがって、女性を中心とした疾病の発生率の上昇が、ウィメンズヘルス市場の拡大に拍車をかけています。

高齢化人口の急増は、ウィメンズヘルス市場の発展を推進する重要なカタリストとして浮上しています。65歳以上の人口比率が急増していることを特徴とする高齢化社会への人口動態の変化により、ウィメンズヘルスのニーズへの注目が高まっています。この層の女性は、骨粗しょう症、乳がん、更年期障害などの疾患の有病率が高いです。このような人口動態の変化は、ウィメンズヘルスの専門的なサービスや商品に対する需要の増大を裏付けています。それは、高齢女性の幸福を維持し、生活の質を高めることを目的とした予防措置、検診、そしてオーダーメイドのヘルスケア介入の重要性を際立たせています。特に、世界保健機関（WHO）の2022年10月の報告書では、2030年までに世界の6人に1人が60歳以上になり、60歳以上の人口は2050年までに倍増して21億人に達すると予測されています。このように、急増する高齢化人口がウィメンズヘルス市場を大きく推進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のウィメンズヘルス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のウィメンズヘルス市場：成長率分析
• 世界のウィメンズヘルス市場の実績：規模と成長, 2019-2024
• 世界のウィメンズヘルス市場の予測：規模と成長, 2024-2029, 2034F
• 世界のウィメンズヘルス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のウィメンズヘルス市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• デバイス
• 薬物
• 医薬品パイプライン
• 世界のウィメンズヘルス市場：年齢別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 50歳以上
• その他の年齢
• 世界のウィメンズヘルス市場：治療タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ホルモン治療
• 非ホルモン治療
• 手術
• 世界のウィメンズヘルス市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のウィメンズヘルス市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 閉経後骨粗鬆症
• ホルモン性不妊症
• 子宮内膜症と子宮筋腫
• 避妊薬
• 閉経
• 多嚢胞性卵巣症候群（PCOS）
• 世界のウィメンズヘルス市場：デバイスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断装置
• 避妊具
• 妊娠モニタリング装置
• 婦人科手術用機器
• 搾乳器
• 世界のウィメンズヘルス市場：薬剤のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ホルモン療法
• 不妊治療薬
• 骨粗鬆症治療薬
• 更年期障害治療薬
• 子宮内膜症治療薬
• 避妊薬
• 世界のウィメンズヘルス市場：医薬品パイプラインのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 更年期障害に対する新たな薬
• 新しい不妊治療
• 新しい避妊法
• 婦人科疾患の治療薬
• ホルモン補充療法の発展

第7章 地域別・国別分析

• 世界のウィメンズヘルス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のウィメンズヘルス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ウィメンズヘルス市場：競合情勢
• ウィメンズヘルス市場：企業プロファイル
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Agile Therapeutics Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Apothecus Pharmaceutical Corporation
• Blairex Laboratories Inc.
• Novartis AG
• AstraZeneca PLC
• F. Hoffmann-La Roche Ltd.
• Ferring Pharmaceuticals
• Lupin Pharmaceuticals Inc.
• Johnson & Johnson Services Inc.
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• Hologic Inc.
• Celmatix Inc.
• HERA Biotech Inc.
• Juno Bio Inc.
• Maven Clinic Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ウィメンズヘルス市場2029：新たな機会を提供する国
• ウィメンズヘルス市場2029：新たな機会を提供するセグメント
• ウィメンズヘルス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Women's health pertains to the area of medicine and healthcare dedicated to diagnosing, treating, and preventing diseases and conditions that uniquely impact women. This field covers various issues, including reproductive health, menstrual health, pregnancy and childbirth, menopause, and conditions like breast and ovarian cancers. It also tackles other health concerns that disproportionately affect women, such as osteoporosis, cardiovascular disease, and autoimmune disorders.

The primary categories of products related to women's health include devices, drugs, and pharmaceutical pipelines. Women's health devices are instrumental in treating medical conditions specific to women. This includes individuals aged 50 years and older, who may undergo hormonal treatment, non-hormonal treatment, and surgeries for a range of applications. These applications span postmenopausal osteoporosis, hormonal infertility, endometriosis, uterine fibroids, contraceptives, menopause, and polycystic ovary syndrome (PCOS). These women's health products are made available through various distribution channels, including hospitals, retail stores, and online pharmacies.

The women's health market research report is one of a series of new reports from The Business Research Company that provides women's health market statistics, including women's health industry global market size, regional shares, competitors with a women's health market share, detailed women's health market segments, market trends and opportunities, and any further data you may need to thrive in the women's health industry. This women's health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The women's health market size has grown steadily in recent years. It will grow from $43.53 billion in 2024 to $45.5 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to advancements in reproductive medicine, awareness and education initiatives, empowerment and advocacy movements, prenatal and postnatal care advances, development of hormone replacement therapies.

The women's health market size is expected to see strong growth in the next few years. It will grow to $58.07 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to precision medicine in gynecology, rise in female-focused clinical trials, expanded use of non-invasive prenatal testing, expanded access to fertility treatments, increasing focus on mental health. Major trends in the forecast period include digital health solutions, fertility tracking and reproductive health, non-hormonal contraceptive options, maternal health and pregnancy monitoring, innovations in women's health diagnostics, integration of artificial intelligence (ai).

The escalating prevalence of women-centric diseases stands as a significant driver propelling the growth trajectory of the women's health market. A surge in conditions such as anemia, osteoporosis, breast cancer, menopause, and others, attributed to diverse risk factors like family history, advancing age, early onset of menstruation or menopause post-55 years, obesity, among others, is fueling the demand for women's health products and services. These offerings cater to treating these diseases while prioritizing the overall health and wellness of women. For example, the American Cancer Society's report published in January 2023 highlighted cervical cancer's historical status as a leading cause of cancer-related deaths among American women. An estimated 13,960 new cases of invasive cervical cancer are projected to be diagnosed in the USA in 2023, with approximately 4,310 anticipated fatalities. Hence, the escalating incidence of women-centric diseases is steering the expansion of the women's health market.

An upsurge in the aging populace emerges as a significant catalyst propelling the advancement of the women's health market. The demographic shift towards an aging population, characterized by a burgeoning proportion of individuals aged 65 and above, necessitates an increased focus on women's health needs. Women within this demographic encounter a higher prevalence of diseases such as osteoporosis, breast cancer, and menopause-related issues. This demographic shift underscores the augmented demand for specialized women's health services and products. It accentuates the significance of preventive measures, screenings, and tailored healthcare interventions aimed at preserving the well-being and enhancing the quality of life for older women. Notably, the World Health Organization's October 2022 report predicts that by 2030, 1 in 6 individuals globally will be aged 60 years or older, with the population of people aged 60 years and older anticipated to double by 2050, reaching 2.1 billion. Thus, the burgeoning aging population significantly propels the women's health market.

Developments in women's health represent a significant trend within the women's health market. Leading companies in this sector are creating new products to bolster their market position. For example, in July 2022, GE Healthcare, a US-based medical technology firm, introduced the Voluson Expert 22. This new addition to the company's women's health portfolio utilizes graphic-based beam former technology, providing exceptional image quality and improved flexibility in imaging capabilities. The system is equipped with advanced tools powered by Artificial Intelligence (AI), ensuring greater consistency in examinations while minimizing the number of tasks needed.

Major players in the women's health market are integrating innovative technologies like Transcutaneous Electrical Nerve Stimulation (TENS) to solidify their position. TENS is a non-invasive therapeutic technique involving a battery-operated device that emits low-voltage electrical currents through electrode pads placed on specific body areas. This technology, exemplified by Myoovi's September 2023 launch in the UK, offers relief for painful menstruation cramps. By generating electrical signals, TENS interferes with and obstructs pain signals attempting to reach the brain, thereby minimizing pain. This drug-free alternative helps women manage the discomfort associated with menstrual cramps, offering a promising solution.

In March 2024, Halma, a UK-based technology firm, acquired Rovers Medical Devices (Rovers) for $92.63 million. This acquisition expands Halma's offerings in the women's health sector, specifically in cervical cancer diagnostics, and supports its objective of enhancing its position in cancer diagnosis products. Rovers Medical Devices, based in the Netherlands, specializes in designing and manufacturing sample collection devices intended for the diagnosis and prevention of cervical cancer.

Major companies operating in the women's health market are AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Apothecus Pharmaceutical Corporation, Blairex Laboratories Inc., Novartis AG, AstraZeneca PLC, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Hologic Inc., Celmatix Inc., HERA Biotech Inc., Juno Bio Inc., Maven Clinic Inc., MobileODT Ltd., Mylan N.V., ObsEva SA, Scailyte AG, Syrona Health AG

North America was the largest region in the women's health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the women's health market report during the forecast period. The regions covered in the women's health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the women's health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The women's health market consists of revenues earned by entities by providing hormone therapy, birth control treatment, and other related services. The market value includes the value of related goods sold by the service provider or included within the service offering. The women's health market also includes sales of contraceptive devices and pharmaceuticals, densitometry, breast implants, obstetrics or gynecology biopsy, imaging devices, and drugs such as Xgeva, Evista, Mirena, Zometa, Reclast, and Class, among others, that are used in providing women's health services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Women's Health Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on women's health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for women's health ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The women's health market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Devices; Drugs; Pharmaceutical Pipeline
• 2) By Age: 50 Years & above ; Other Ages
• 3) By Treatment Type: Hormonal Treatment; Non-Hormonal Treatment; Surgeries
• 4) By Application: Postmenopausal Osteoporosis; Hormonal Infertility; Endometriosis & Uterine Fibroids; Contraceptives; Menopause; Polycystic Ovary Syndrome (PCOS)
• 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Devices: Diagnostic Devices; Contraceptive Devices; Fertility Monitoring Devices; Gynecological Surgical Devices; Breast Pumps
• 2) By Drugs: Hormonal Therapies; Fertility Drugs; Osteoporosis Drugs; Menopause Treatment Drugs; Endometriosis Drugs; Contraceptives
• 3) By Pharmaceutical Pipeline: Emerging Drugs for Menopause; New Fertility Treatments; Novel Contraceptives; Drugs for Gynecological Conditions; Hormone Replacement Therapy Developments
• Companies Mentioned: AbbVie Inc.; Bayer AG; Merck & Co Inc.; Pfizer Inc.; Agile Therapeutics
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Women's Health Market Characteristics

3. Women's Health Market Trends And Strategies

4. Women's Health Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Women's Health Growth Analysis And Strategic Analysis Framework

• 5.1. Global Women's Health PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Women's Health Market Growth Rate Analysis
• 5.4. Global Women's Health Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Women's Health Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Women's Health Total Addressable Market (TAM)

6. Women's Health Market Segmentation

• 6.1. Global Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Devices
• Drugs
• Pharmaceutical Pipeline
• 6.2. Global Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 50 Years & above
• Other Ages
• 6.3. Global Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormonal Treatment
• Non-Hormonal Treatment
• Surgeries
• 6.4. Global Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Women's Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Postmenopausal Osteoporosis
• Hormonal Infertility
• Endometriosis & Uterine Fibroids
• Contraceptives
• Menopause
• Polycystic Ovary Syndrome (PCOS)
• 6.6. Global Women's Health Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Devices
• Contraceptive Devices
• Fertility Monitoring Devices
• Gynecological Surgical Devices
• Breast Pumps
• 6.7. Global Women's Health Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormonal Therapies
• Fertility Drugs
• Osteoporosis Drugs
• Menopause Treatment Drugs
• Endometriosis Drugs
• Contraceptives
• 6.8. Global Women's Health Market, Sub-Segmentation Of Pharmaceutical Pipeline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Emerging Drugs for Menopause
• New Fertility Treatments
• Novel Contraceptives
• Drugs for Gynecological Conditions
• Hormone Replacement Therapy Developments

7. Women's Health Market Regional And Country Analysis

• 7.1. Global Women's Health Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Women's Health Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Women's Health Market

• 8.1. Asia-Pacific Women's Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Women's Health Market

• 9.1. China Women's Health Market Overview
• 9.2. China Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Women's Health Market

• 10.1. India Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Women's Health Market

• 11.1. Japan Women's Health Market Overview
• 11.2. Japan Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Women's Health Market

• 12.1. Australia Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Women's Health Market

• 13.1. Indonesia Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Women's Health Market

• 14.1. South Korea Women's Health Market Overview
• 14.2. South Korea Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Women's Health Market

• 15.1. Western Europe Women's Health Market Overview
• 15.2. Western Europe Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Women's Health Market

• 16.1. UK Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Women's Health Market

• 17.1. Germany Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Women's Health Market

• 18.1. France Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Women's Health Market

• 19.1. Italy Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Women's Health Market

• 20.1. Spain Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Women's Health Market

• 21.1. Eastern Europe Women's Health Market Overview
• 21.2. Eastern Europe Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Women's Health Market

• 22.1. Russia Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Women's Health Market

• 23.1. North America Women's Health Market Overview
• 23.2. North America Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Women's Health Market

• 24.1. USA Women's Health Market Overview
• 24.2. USA Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Women's Health Market

• 25.1. Canada Women's Health Market Overview
• 25.2. Canada Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Women's Health Market

• 26.1. South America Women's Health Market Overview
• 26.2. South America Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Women's Health Market

• 27.1. Brazil Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Women's Health Market

• 28.1. Middle East Women's Health Market Overview
• 28.2. Middle East Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Women's Health Market

• 29.1. Africa Women's Health Market Overview
• 29.2. Africa Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Women's Health Market Competitive Landscape And Company Profiles

• 30.1. Women's Health Market Competitive Landscape
• 30.2. Women's Health Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Agile Therapeutics Overview, Products and Services, Strategy and Financial Analysis

31. Women's Health Market Other Major And Innovative Companies

• 31.1. Apothecus Pharmaceutical Corporation
• 31.2. Blairex Laboratories Inc.
• 31.3. Novartis AG
• 31.4. AstraZeneca PLC
• 31.5. F. Hoffmann-La Roche Ltd.
• 31.6. Ferring Pharmaceuticals
• 31.7. Lupin Pharmaceuticals Inc.
• 31.8. Johnson & Johnson Services Inc.
• 31.9. Eli Lilly and Company
• 31.10. Teva Pharmaceutical Industries Ltd.
• 31.11. Hologic Inc.
• 31.12. Celmatix Inc.
• 31.13. HERA Biotech Inc.
• 31.14. Juno Bio Inc.
• 31.15. Maven Clinic Inc.

32. Global Women's Health Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Women's Health Market

34. Recent Developments In The Women's Health Market

35. Women's Health Market High Potential Countries, Segments and Strategies

• 35.1 Women's Health Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Women's Health Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Women's Health Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer